These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26469347)

  • 41. An outbreak of intestinal schistosomiasis, alongside increasing urogenital schistosomiasis prevalence, in primary school children on the shoreline of Lake Malawi, Mangochi District, Malawi.
    Kayuni SA; O'Ferrall AM; Baxter H; Hesketh J; Mainga B; Lally D; Al-Harbi MH; LaCourse EJ; Juziwelo L; Musaya J; Makaula P; Stothard JR
    Infect Dis Poverty; 2020 Aug; 9(1):121. PubMed ID: 32867849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urogenital schistosomiasis in Nigeria post receipt of the largest single praziquantel donation in Africa.
    Enabulele EE; Platt RN; Adeyemi E; Agbosua E; Aisien MSO; Ajakaye OG; Ali MU; Amaechi EC; Atalabi TE; Auta T; Awosolu OB; Dagona AG; Edo-Taiwo O; Ejikeugwu CEP; Igbeneghu C; Njom VS; Orji MN; Oyinloye FOP; Ozemoka HJ; Ugah UI; Anderson TJC
    Acta Trop; 2021 Jul; 219():105916. PubMed ID: 33878306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
    Barakat R; El Morshedy H
    Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
    Kovač J; Vargas M; Keiser J
    Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of praziquantel efficacy at 40 mg/kg and 60 mg/kg in treating Schistosoma haematobium infection among schoolchildren in the Ingwavuma area, KwaZulu-Natal, South Africa.
    Kabuyaya M; Chimbari MJ; Mukaratirwa S
    S Afr Med J; 2020 Jul; 110(7):657-660. PubMed ID: 32880343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies.
    Richter J
    Acta Trop; 2000 Oct; 77(1):111-31. PubMed ID: 10996127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome-wide insights into adaptive hybridisation across the Schistosoma haematobium group in West and Central Africa.
    Landeryou T; Rabone M; Allan F; Maddren R; Rollinson D; Webster BL; Tchuem-Tchuenté LA; Anderson RM; Emery AM
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010088. PubMed ID: 35100291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in northern Senegal.
    Meurs L; Mbow M; Vereecken K; Menten J; Mboup S; Polman K
    Int J Parasitol; 2012; 42(3):305-11. PubMed ID: 22366733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in Zimbabwe.
    Zinyama-Gutsire R; Gomo E; Kallestrup P; Erikstrup C; Ullum H; Butterworth AE; Munyati S; Mduluza T
    BMC Infect Dis; 2009 Oct; 9():174. PubMed ID: 19852800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Population genetic structure of Schistosoma mansoni and Schistosoma haematobium from across six sub-Saharan African countries: implications for epidemiology, evolution and control.
    Gower CM; Gouvras AN; Lamberton PH; Deol A; Shrivastava J; Mutombo PN; Mbuh JV; Norton AJ; Webster BL; Stothard JR; Garba A; Lamine MS; Kariuki C; Lange CN; Mkoji GM; Kabatereine NB; Gabrielli AF; Rudge JW; Fenwick A; Sacko M; Dembelé R; Lwambo NJ; Tchuem Tchuenté LA; Rollinson D; Webster JP
    Acta Trop; 2013 Nov; 128(2):261-74. PubMed ID: 23041540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistance of Schistosoma mansoni to praziquantel: is there a problem?
    Doenhoff MJ; Kusel JR; Coles GC; Cioli D
    Trans R Soc Trop Med Hyg; 2002; 96(5):465-9. PubMed ID: 12474468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial.
    Hoekstra PT; Casacuberta Partal M; Amoah AS; van Lieshout L; Corstjens PLAM; Tsonaka S; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
    BMC Infect Dis; 2018 Dec; 18(1):662. PubMed ID: 30547750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
    Taylor P; Murare HM; Manomano K
    J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.
    Coeli R; Baba EH; Araujo N; Coelho PM; Oliveira G
    PLoS Negl Trop Dis; 2013; 7(12):e2596. PubMed ID: 24367712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
    Mutapi F; Rujeni N; Bourke C; Mitchell K; Appleby L; Nausch N; Midzi N; Mduluza T
    PLoS Negl Trop Dis; 2011 May; 5(5):e1143. PubMed ID: 21610855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal.
    Danso-Appiah A; De Vlas SJ
    Trends Parasitol; 2002 Mar; 18(3):125-9. PubMed ID: 11854090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Schistosomiasis - Assessing Progress toward the 2020 and 2025 Global Goals.
    Deol AK; Fleming FM; Calvo-Urbano B; Walker M; Bucumi V; Gnandou I; Tukahebwa EM; Jemu S; Mwingira UJ; Alkohlani A; Traoré M; Ruberanziza E; Touré S; Basáñez MG; French MD; Webster JP
    N Engl J Med; 2019 Dec; 381(26):2519-2528. PubMed ID: 31881138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined Schistosoma mansoni and Schistosoma haematobium infection.
    Mahmood A; Yasir M
    J Coll Physicians Surg Pak; 2005 Jul; 15(7):443-4. PubMed ID: 16197880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of circulating schistosome antigens in serum and urine of schistosomiasis patients and assessment of cure by a monoclonal antibody.
    Demerdash ZA; Mohamed SH; Shaker ZA; Hassan SI; el Attar GM; Din AH; Abadeer NI; Mansour MM
    J Egypt Soc Parasitol; 1995 Aug; 25(2):471-84. PubMed ID: 7665943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya.
    Black CL; Steinauer ML; Mwinzi PN; Evan Secor W; Karanja DM; Colley DG
    Trop Med Int Health; 2009 Apr; 14(4):450-7. PubMed ID: 19222824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.